Xtx Topco LTD G1 Therapeutics, Inc. Transaction History

Xtx Topco LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$2.2 - $4.98 $23,579 - $53,375	10,718 Added 104.04%	21,020 $47,000
Q1 2024 May 13, 2024	SELL	$2.1 - $4.83 $308,487 - $709,522	-146,899 Reduced 93.45%	10,302 $44,000
Q4 2023 Feb 13, 2024	SELL	$1.12 - $3.73 $156,128 - $519,962	-139,400 Reduced 47.0%	157,201 $479,000
Q3 2023 Nov 13, 2023	BUY	$1.22 - $2.67 $227,838 - $498,630	186,753 Added 170.01%	296,601 $427,000
Q2 2023 Aug 14, 2023	SELL	$2.46 - $3.14 $453,732 - $579,154	-184,444 Reduced 62.67%	109,848 $273,000
Q1 2023 May 12, 2023	BUY	$2.57 - $8.16 $493,465 - $1.57 Million	192,010 Added 187.73%	294,292 $788,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $453,320 - $1.18 Million	87,345 Added 584.76%	102,282 $555,000
Q3 2022 Nov 14, 2022	SELL	$5.17 - $16.99 $158,300 - $520,216	-30,619 Reduced 67.21%	14,937 $187,000
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $184,046 - $387,681	45,556 New	45,556 $225,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.